Biochemistry Moscow-Supplement Series B-Biomedical Chemistry

Scope & Guideline

Exploring the Frontiers of Biomedical Chemistry for a Healthier Tomorrow.

Introduction

Welcome to the Biochemistry Moscow-Supplement Series B-Biomedical Chemistry information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of Biochemistry Moscow-Supplement Series B-Biomedical Chemistry, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN1990-7508
PublisherMAIK NAUKA-INTERPERIODICA
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 2008 to 2024
AbbreviationBIOCHEM MOSC SUPPL B / Biochem. Mosc.-Suppl. Ser. B-Biomed. Chem.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressPROFSOYUZNAYA UL 90, MOSCOW 117997, RUSSIA

Aims and Scopes

The journal "Biochemistry Moscow-Supplement Series B-Biomedical Chemistry" primarily focuses on the intersection of biochemistry and biomedical research, aiming to advance knowledge in areas that are critical for understanding disease mechanisms, therapeutic development, and biochemical processes.
  1. Molecular Mechanisms in Disease:
    Research often delves into the molecular underpinnings of various diseases, including cancer, cardiovascular conditions, and metabolic disorders, highlighting the biochemical pathways involved.
  2. Biochemical Markers and Diagnostics:
    The journal emphasizes the identification and validation of biochemical markers that can serve as diagnostic tools or therapeutic targets, reflecting a commitment to translational research.
  3. Innovative Therapeutic Approaches:
    A significant focus is placed on developing new therapeutic strategies, including the exploration of small molecules, peptides, and biologics, as potential treatments for diseases.
  4. Technological Advances in Biochemistry:
    The journal showcases studies utilizing cutting-edge methodologies such as molecular dynamics simulations, RNA sequencing, and in silico modeling to enhance understanding of biochemical processes.
  5. Interdisciplinary Research:
    Research often integrates concepts from various disciplines, including genetics, microbiology, and pharmacology, demonstrating the journal's commitment to holistic approaches in biomedical research.
The journal has shown a dynamic evolution in its research focus, with several emerging themes gaining traction in recent years. These trends reflect both advancements in technology and a growing emphasis on precision medicine and personalized healthcare.
  1. Omics Technologies in Cancer Research:
    Recent publications indicate an increasing use of omics technologies (genomics, proteomics, metabolomics) to understand cancer biology, which is crucial for developing targeted therapies.
  2. MicroRNA and Non-Coding RNA Research:
    There is a growing interest in the role of microRNAs and other non-coding RNAs as biomarkers and therapeutic targets, reflecting a trend towards understanding gene regulation and its implications in disease.
  3. Artificial Intelligence and Machine Learning Applications:
    The introduction of AI and machine learning methods in biochemistry, such as for binding site prediction, represents a significant trend, highlighting the journal's commitment to integrating modern computational tools in biomedical research.
  4. Focus on Aging and Age-Related Diseases:
    Research on aging and related diseases, such as sarcopenia and age-related macular degeneration, is increasingly prominent, indicating a broader interest in how biochemical processes affect aging populations.
  5. Biochemical Interactions in Immune Responses:
    Emerging studies exploring the biochemical interactions in immune responses, particularly in the context of infections like SARS-CoV-2, show a rising focus on immunology and its biochemical foundations.

Declining or Waning

While the journal has consistently covered a wide range of topics in biochemistry and biomedical chemistry, certain themes appear to be declining in prominence based on recent publication trends.
  1. Traditional Pharmacological Studies:
    There seems to be a waning interest in purely traditional pharmacological studies, as the focus shifts towards more innovative and interdisciplinary approaches to drug discovery and development.
  2. Basic Biochemical Processes:
    Research emphasizing basic biochemical processes without direct clinical relevance appears to be decreasing, as the journal pivots towards studies that have clear implications for health and disease.
  3. Animal Model Studies:
    There is a noticeable decline in the number of studies exclusively relying on animal models, suggesting a shift towards more human-relevant research methodologies, including in vitro and clinical studies.

Similar Journals

Journal of Medical Biochemistry

Empowering Discoveries in Medical Biochemistry
Publisher: SOC MEDICAL BIOCHEMISTS SERBIAISSN: 1452-8258Frequency: 4 issues/year

Journal of Medical Biochemistry is a distinguished peer-reviewed journal published by the SOC MEDICAL BIOCHEMISTS SERBIA, focusing on the significant intersection of biochemistry and medicine. With an e-ISSN of 1452-8266, this Open Access journal has been enriching the academic community since 2007, providing vital insights and research findings that advance the field of medical biochemistry. Based in Belgrade, Serbia, the journal plays a pivotal role in disseminating contemporary research, highlighted by its impressive standings in the 2023 quartile rankings, featuring Q2 in Medical Biochemistry and Q3 in Clinical Biochemistry. The journal is recognized in Scopus with rankings that position it within the discerning area of medical biochemistry and clinical biochemistry, attesting to its influence and relevance. By promoting innovative research and facilitating an open exchange of scientific ideas, the Journal of Medical Biochemistry is a crucial resource for researchers, professionals, and students dedicated to uncovering the biochemical underpinnings essential to improving human health.

BIOCHEMICAL JOURNAL

Driving Scientific Excellence in Biochemistry
Publisher: PORTLAND PRESS LTDISSN: 0264-6021Frequency: 24 issues/year

BIOCHEMICAL JOURNAL, published by Portland Press Ltd, stands as a leading publication in the fields of Biochemistry, Cell Biology, and Molecular Biology, reflecting a commitment to advancing scientific knowledge since its inception in 1945. With a distinguished Q1 ranking across these categories and impressive Scopus rankings, the journal serves as an invaluable resource for researchers, professionals, and students alike, facilitating critical discoveries and innovative research practices. Although not currently offering open access, the journal provides a platform for high-quality peer-reviewed articles, ensuring rigorous standards in the dissemination of biochemical research. Spanning over seven decades and continuing through to 2024, the BIOCHEMICAL JOURNAL fosters an environment where cutting-edge biochemical research thrives, supporting the global scientific community's efforts to address complex biological questions and enhance our understanding of fundamental cellular processes.

Annual Review of Biochemistry

Pioneering Reviews for the Biochemical Community
Publisher: ANNUAL REVIEWSISSN: 0066-4154Frequency: 1 issue/year

Annual Review of Biochemistry is a premier publication in the field of biochemistry, renowned for its comprehensive and critical reviews that collate significant advancements and insights since its inception in 1946. Published by Annual Reviews in the United States, this journal maintains a prestigious position within the academic community, boasting a Q1 ranking in the biochemistry category for 2023, with an impressive Scopus rank of #4 out of 438, placing it in the top 1% of its field. With a commitment to excellence, it serves as an essential resource for researchers, professionals, and students striving to stay at the forefront of biochemical research. While the journal does not operate on an open-access model, it continues to provide key insights and knowledge that fuel innovation and discovery in the life sciences. As it converges research from various eras up to 2024, Annual Review of Biochemistry remains a vital contributor to the development of molecular biology and genetics, catering to the needs of a diverse readership keen on advancing their understanding and expertise in biochemistry.

HORMONE AND METABOLIC RESEARCH

Unraveling the Complexities of Hormonal Influence
Publisher: GEORG THIEME VERLAG KGISSN: 0018-5043Frequency: 12 issues/year

HORMONE AND METABOLIC RESEARCH, published by GEORG THIEME VERLAG KG, stands as a reputable platform in the fields of biochemistry, endocrinology, and metabolism since its establishment in 1969. This peer-reviewed journal provides critical insights and advancements in the intricate relationships between hormones and metabolic processes, catering to researchers, healthcare professionals, and students alike. With an impressive convergence of knowledge spanning over five decades, it maintains a commendable Q3 ranking in multiple categories, including Biochemistry, Clinical Biochemistry, and Endocrinology, highlighting its contribution to cutting-edge scientific discourse. Although not an open-access journal, it offers a plethora of access options for readers and institutions, ensuring that vital research reaches those who need it most. Located in Stuttgart, Germany, the journal is positioned at the forefront of influential research in hormone and metabolic studies, emphasizing its importance for ongoing investigations into health and disease.

Byulleten Sibirskoy Meditsiny

Exploring the Frontiers of Molecular Mechanisms and Therapies
Publisher: SIBERIAN STATE MEDICAL UNIVISSN: 1682-0363Frequency: 6 issues/year

Byulleten Sibirskoy Meditsiny, published by the Siberian State Medical University, is a pivotal open-access journal in the field of Molecular Medicine, with its current edition indexed under the ISSN 1682-0363. Since its transition to open access in 2013, the journal aims to disseminate high-quality research and advancements in biomedical sciences, particularly focusing on molecular mechanisms and therapeutic interventions. Despite its relatively recent recognition in Molecular Medicine, where it ranks in the 6th percentile, the journal is dedicated to fostering knowledge exchange and collaboration among researchers, professionals, and students alike. With a modest impact factor and quarterly publication, Byulleten Sibirskoy Meditsiny is positioned to serve as a valuable resource for those engaged in the intricate realms of molecular biology, biochemistry, and general medicine, contributing to the broader scientific discourse in the Russian Federation and beyond.

JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION

Driving Innovation in Biochemical Research
Publisher: TAYLOR & FRANCIS LTDISSN: 1079-9893Frequency: 6 issues/year

JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION, published by TAYLOR & FRANCIS LTD, is a premier academic journal dedicated to advancing our understanding of receptor biology and signal transduction mechanisms. With an ISSN of 1079-9893 and an E-ISSN of 1532-4281, this journal has maintained a reputable standing since its inception in 1980, continually addressing pivotal topics in biochemistry, cell biology, and molecular biology. As evidenced by its 2023 Scopus rankings, which place it in the 64th percentile for Biochemistry and Genetics and Molecular Biology, JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION remains a vital source for cutting-edge research, providing insights that are essential for both academic and practical applications. Although the journal currently offers limited open access options, it stands out in the Q2 and Q3 quartiles of its respective categories, making it an invaluable resource for researchers, professionals, and students aiming to stay abreast of the latest findings and methodologies in receptor and signaling research. The journal's commitment to disseminating high-quality research underscores its significance within the scientific community, fostering innovation and collaboration across disciplines.

Frontiers in Molecular Biosciences

Pioneering Discoveries in Biochemistry and Genetics
Publisher: FRONTIERS MEDIA SAISSN: Frequency: 1 issue/year

Frontiers in Molecular Biosciences is an esteemed open-access journal published by FRONTIERS MEDIA SA, based in Switzerland. Since its inception in 2014, the journal has made significant strides in the fields of biochemistry, genetics, and molecular biology, cementing its reputation with a solid position in the Q1 quartile for both Biochemistry and Genetics and Molecular Biology (miscellaneous) categories as of 2023. With a remarkable Scopus rank of #14/103 in the combined categories, it offers an essential platform for the dissemination of high-quality research that shapes the understanding of molecular processes and their implications in health and disease. The journal’s commitment to open access facilitates the broadest possible reach for groundbreaking discoveries, serving as a vital resource for researchers, professionals, and students alike. Located at AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, this journal continues to foster innovative discussions and advancements in molecular biosciences, paving the way for new insights and collaborations in the scientific community.

PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS

Fostering Global Collaboration in Biochemical Research
Publisher: CHINESE ACAD SCIENCES, INST BIOPHYSICSISSN: 1000-3282Frequency: 12 issues/year

PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, published by the Chinese Academy of Sciences, Institute of Biophysics, serves as a vital platform for advancing the field of biochemistry and biophysics. With a legacy dating from 1996 through 2024, this journal has been instrumental in disseminating critical research findings and innovative methodologies that push the boundaries of our understanding of biochemical processes and biophysical phenomena. Though currently unlisted as Open Access, the journal embodies rigorous peer-reviewed scholarship, positioned in the competitive Q4 quartile for both biochemistry and biophysics categories as per the 2023 metrics. It caters to a diverse audience, including researchers, professionals, and students who are keen to explore foundational and emerging concepts within these dynamic fields. By publishing comprehensive studies and reviews, the journal not only highlights progress but also fosters collaboration and dialogue among scholars worldwide, making it an essential resource for anyone invested in biochemical and biophysical research.

Biochemistry Research International

Exploring the depths of molecular interactions and processes.
Publisher: HINDAWI LTDISSN: 2090-2247Frequency: 1 issue/year

Biochemistry Research International is a prominent and dynamic journal published by Hindawi Ltd, dedicated to advancing knowledge in the field of biochemistry. With its Open Access model established since 2010, the journal provides unrestricted access to high-quality research, thereby fostering global communication among researchers and professionals. Operating out of the United States, Biochemistry Research International serves as a vital platform for disseminating cutting-edge findings in biochemistry and molecular biology, holding a respectable Q2 ranking in its category as of 2023. The journal's scope encompasses a wide array of topics including but not limited to biochemical processes, genetic engineering, and molecular interactions, making it an essential resource for students and seasoned researchers alike. With an impact factor reflective of its significance in the academic community, Biochemistry Research International continues to play an integral role in shaping the future of biochemistry research.

ACTA BIOCHIMICA POLONICA

Pioneering Research for Tomorrow's Scientific Breakthroughs
Publisher: ACTA BIOCHIMICA POLONICAISSN: 0001-527XFrequency: 4 issues/year

ACTA BIOCHIMICA POLONICA (ISSN: 0001-527X, E-ISSN: 1734-154X) is a distinguished journal published by the ACTA BIOCHIMICA POLONICA in Poland, with a rich history dating back to 1955. As a prominent platform for disseminating research, it currently holds a Category Quartile of Q3 in the fields of Biochemistry, Genetics, and Molecular Biology, reflecting its commitment to advancing knowledge in these critical areas. This journal is indexed in Scopus, ranking 124 out of 221, placing it in the 44th percentile among general biochemistry, genetics, and molecular biology journals. Although it does not operate under an open-access model, ACTA BIOCHIMICA POLONICA remains a vital resource for researchers, professionals, and students seeking to delve into the latest developments and discoveries in biochemistry and molecular biology. Its strategic focus on contemporary topics ensures that it plays an essential role in shaping future scientific inquiries and fostering collaboration across various disciplines.